BIA MEP Brexit briefing, June 2019

Opening for participation on September 2nd 2026, PIR International’s 2027 EU/UK Biotech & Life Sciences Board Remuneration & Diversity Study will provide a comprehensive, data-driven view of board remuneration, composition and diversity across the European and UK life sciences sector.

Agilent Technologies has been announced as a founding member of Harwell’s new CO:LABS development.

Chris Molloy on Mike Hoare, the RedX-Skye deal, Stablepharma’s fridge-free vaccine, MHRA quarterly numbers, ministerial responsibilities for UK life sciences and human biology-based models

Mironid raises $46 million in Series B financing to advance clinical development of its treatment for rare kidney disease

BIA Annual General Meeting 2026: nominations open for BIA Board election

The advantages to building a business in the UK's biotech clusters